PGR and breast cancer: To determine whether HP could suppress osteolytic bone metastasis and osteolysis, nude mice were injected intratibially with human breast cancer MDA-MB-231 cells, which are triple negative (negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2).